CVS is now selling a rival generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.
WASHINGTON (AP) — The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.
DES MOINES, Iowa (AP) — Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs.